Skip to Content

U.S. COVID-19 Death Toll Hits 300,000 as Vaccine Rollout Begins

TUESDAY, Dec. 15, 2020 -- The number of Americans killed by COVID-19 topped 300,000 on Monday, the same day the country launched a massive vaccination campaign to curb the spread of COVID-19.

And on Tuesday morning, scientists from the U.S. Food and Drug Administration released a data review that almost guarantees a second vaccine will soon join the Pfizer vaccine that was sent out on Monday: The two-shot Moderna regimen, which is based on the same technology as the Pfizer vaccine, was found to be 94 percent effective in a clinical trial and carried no serious safety concerns. The glowing assessment positions the Moderna vaccine for approval from an FDA advisory panel that is meeting on Thursday, The Washington Post reported.

As the first doses of the Pfizer vaccine made their way to the arms of health care workers around the United States, a new survey from the Kaiser Family Foundation showed that 71 percent of Americans say they will "definitely or probably" get a COVID-19 vaccine.

That is up from 63 percent in September, and it is a sign that a growing number of Americans are starting to trust the science behind the vaccines as they become more comfortable with the speed in which the vaccines are being developed.

The Washington Post Article

KFF COVID-19 Vaccine Monitor

© 2021 HealthDay. All rights reserved.

Posted: December 2020

Read this next

Certain Factors Increase Pandemic's Psychological Impact on College Students

WEDNESDAY, Jan. 27, 2021 -- Certain risk factors are associated with college students self-reporting a psychological impact of the COVID-19 pandemic, according to a study...

Retired Doctors, Nurses Will Be Approved to Give COVID-19 Vaccine, White House Says

WEDNESDAY, Jan. 27, 2021 -- Retired doctors and nurses are being called to the front lines of the U.S. COVID-19 vaccination effort, the White House COVID-19 Response team...

Respiratory, Physical, Psych Sequelae ID'd After COVID-19 Discharge

WEDNESDAY, Jan. 27, 2021 -- For patients hospitalized with COVID-19, respiratory, physical, and psychological sequelae are common at four months after discharge, according to a...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.